Signup Crypto ETF Stocks News

Kuehn Law Encourages Investors of SoundHound AI, Inc. to Contact Law Firm - SoundHound AI ( NASDAQ:SOUN )

NEW YORK, May 19, 2025 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SoundHound AI, Inc. SOUN breached their fiduciary duties to shareholders.

Source: www.benzinga.com
May 19, 2025 | 22:10:10
Category: News

$1000 Invested In Spotify Technology 5 Years Ago Would Be Worth This Much Today - Spotify Technology ( NYSE:SPOT )

Spotify Technology SPOT has outperformed the market over the past 5 years by 13.41% on an annualized basis producing an average annual return of 28.44%. Currently, Spotify Technology has a market capitalization of $136.26 billion.

Source: www.benzinga.com
May 19, 2025 | 22:15:23
Category: Trading

GM Announces The End Of Car Exports To China - Ford Motor ( NYSE:F ) , General Motors ( NYSE:GM )

GM's exports to China are facilitated through its Durant Guild premium import division. As part of its restructuring, GM is closing its plant in Shenyang, China. Beat the market with ready-to-go trades and pro tools-now 60% off for Memorial Day.

Source: www.benzinga.com
May 19, 2025 | 22:23:17
Category: News

What's Going On With Microsoft Stock? - Microsoft ( NASDAQ:MSFT )

Microsoft stock is rising as investors react positively to AI-driven cost savings and momentum in cloud and AI. Microsoft announces the addition of xAI's Grok and other AI tools for Azure data centers at its Build developer conference. Get 5 'Hidden Gem' stock picks and daily rankings-now 60% ...

Source: www.benzinga.com
May 19, 2025 | 20:13:27
Category: News

Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference

VANCOUVER, British Columbia, May 19, 2025 ( GLOBE NEWSWIRE ) -- Zymeworks Inc. ( Nasdaq: ZYME ) , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, ...

Source: www.globenewswire.com
May 19, 2025 | 20:15:00
Category: News

NCS Multistage Holdings, Inc. to Present at the Emerging Growth Conference

HOUSTON, May 19, 2025 ( GLOBE NEWSWIRE ) -- NCS Multistage Holdings, Inc. ( "NCS" or the "Company" ) ( NASDAQ:NCSM ) announced today that Ryan Hummer, Chief Executive Officer, is scheduled to present at the Emerging Growth Conference on Wednesday, May 21, 2025 at 1:55 p.m. Central Time ( 2:55 p.m.

Source: www.globenewswire.com
May 19, 2025 | 20:15:00
Category: News

BitMine Launches Bitcoin Treasury Advisory Practice and Enters into $4M Transaction with First BTC Treasury Advisory Client - BitMine Immersion Techs ( OTC:BMNRD )

LAS VEGAS, May 19, 2025 ( GLOBE NEWSWIRE ) -- BitMine Immersion Technologies, Inc. BMNRD today announced the launch of its Bitcoin Treasury Advisory Practice, alongside a $4 million strategic transaction with a U.S. exchange-listed company.

Source: www.benzinga.com
May 19, 2025 | 20:15:00
Category: General

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies - CRISPR Therapeutics ( NASDAQ:CRSP )

-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI ( FXI ) small interfering RNA ( siRNA ) for the treatment of thromboembolic disorders-

Source: www.benzinga.com
May 19, 2025 | 20:15:00
Category: General

Opendoor Announces Closing of Convertible Notes Exchange and New Convertible Notes Issuance

SAN FRANCISCO, May 19, 2025 ( GLOBE NEWSWIRE ) -- Opendoor Technologies Inc. ( Nasdaq: OPEN ) ( the "Company" ) , a leading e-commerce platform for residential real estate transactions, today announced the completion of its negotiated exchange and subscription agreements ( the "Exchange and ...

Source: www.globenewswire.com
May 19, 2025 | 20:15:00
Category: News

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI ( FXI ) small interfering RNA ( siRNA ) for the treatment of thromboembolic ...

Source: www.globenewswire.com
May 19, 2025 | 20:15:00
Category: News

© Natavest 2025 - 2026